---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-003536"
form_type: "8-K"
ticker: "INKT"
cik: "0001840229"
company_name: "MiNK Therapeutics, Inc."
filed_at: "2022-01-06T23:59:59+00:00"
generated_at: "2026-06-27T20:20:24.661270+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "medium"
source: SEC EDGAR
---

# MiNK Therapeutics board member Dr. Walter Flamenbaum retires as planned

## Summary
- Dr. Walter Flamenbaum retired from the Board of Directors effective December 31, 2021.
- His retirement was previously disclosed in the Company's Amended Registration Statement filed on October 12, 2021.
- No immediate replacement was announced; the departure was part of a previously planned transition.

## SEC filing metadata
- accession: 0001193125-22-003536
- form_type: 8-K
- ticker: INKT
- cik: 0001840229
- company_name: MiNK Therapeutics, Inc.
- filed_at: 2022-01-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: medium
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840229/000119312522003536/0001193125-22-003536-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840229/000119312522003536/d268923d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-003536
- JSON: https://secwatch.observer/filing/0001193125-22-003536.json
- Plain text: https://secwatch.observer/filing/0001193125-22-003536.txt

## Key facts
- Executive change
  Walter Flamenbaum retired as Director at MiNK Therapeutics, Inc..
  - Action: retired
  - Role: Director
  source text: Dr. Walter Flamenbaum retired from the Board of Directors of MiNK Therapeutics, Inc. (the “Company”), effective December 31, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840229/000119312522003536/0001193125-22-003536-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.